• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-29a 通过靶向 CDC42/PAK1 信号通路抑制宫颈癌中的细胞增殖和迁移。

MiR-29a inhibits cell proliferation and migration by targeting the CDC42/PAK1 signaling pathway in cervical cancer.

机构信息

Department of Gynaecology and Obstetrics, The First Affiliated Hospital of Hunan Normal University.

Department of Anesthesiology, The Third Xiangya Hospital, Central South University, Changsha, People's Republic of China.

出版信息

Anticancer Drugs. 2019 Jul;30(6):579-587. doi: 10.1097/CAD.0000000000000743.

DOI:10.1097/CAD.0000000000000743
PMID:30724771
Abstract

Cervical cancer is the second most common gynecological malignancy worldwide and the tumorigenesis mechanisms of cervical cancer are still unclear. This study aimed to reveal the role of miR-29a in cervical cancer. The expression level of miR-29a and CDC42 was measured using qRT-PCR. Cell proliferation, apoptosis, migration, and invasion were detected using colony formation, flow cytometry analysis, wound-healing assay, and Transwell assay, respectively. Luciferase reporter assay was used to determine the binding of miR-29a with CDC42. CDC42/p21-activated kinase 1 (PAK1) pathway-related proteins were measured by western blotting. MiR-29a was downregulated and CDC42 was upregulated in cervical cancer cells. Luciferase reporter assay showed that miR-29a negatively regulated the expression of CDC42 by directly targeting 3'-UTR of CDC42. Cell proliferation, migration, and invasion were markedly inhibited, whereas cell apoptosis was significantly increased in Hela and CaSki cells transfected with miR-29a mimics. These effects were partly recovered by CDC42 overexpression. Protein levels of PAK1, p-PAK1, p-LIMK, and p-cofilin were significantly downregulated by miR-29a mimics, which was reversed by CDC42 overexpression and was increased by the miR-29a inhibitor. MiR-29a inhibited cell proliferation, migration, and invasion, as well as promoted cell apoptosis through repressing the PAK1/LIMK signaling pathway by targeting CDC42 in cervical cancer.

摘要

宫颈癌是全球第二大常见的妇科恶性肿瘤,其肿瘤发生机制仍不清楚。本研究旨在揭示 miR-29a 在宫颈癌中的作用。采用 qRT-PCR 检测 miR-29a 和 CDC42 的表达水平。通过集落形成、流式细胞术分析、划痕愈合试验和 Transwell 试验分别检测细胞增殖、凋亡、迁移和侵袭。采用荧光素酶报告实验确定 miR-29a 与 CDC42 的结合。通过 Western blot 检测 CDC42/p21 激活激酶 1(PAK1)通路相关蛋白。结果显示,宫颈癌细胞中 miR-29a 下调,CDC42 上调。荧光素酶报告实验表明,miR-29a 通过直接靶向 CDC42 的 3'-UTR 负调控 CDC42 的表达。转染 miR-29a 模拟物的 Hela 和 CaSki 细胞中,细胞增殖、迁移和侵袭明显受到抑制,而细胞凋亡显著增加。CDC42 的过表达部分恢复了这些效应。miR-29a 模拟物显著下调 PAK1、p-PAK1、p-LIMK 和 p-cofilin 的蛋白水平,而 CDC42 的过表达逆转了这一效应,miR-29a 抑制剂则增加了这一效应。miR-29a 通过靶向 CDC42 抑制 PAK1/LIMK 信号通路,抑制细胞增殖、迁移和侵袭,并促进细胞凋亡,从而抑制宫颈癌的发生。

相似文献

1
MiR-29a inhibits cell proliferation and migration by targeting the CDC42/PAK1 signaling pathway in cervical cancer.miR-29a 通过靶向 CDC42/PAK1 信号通路抑制宫颈癌中的细胞增殖和迁移。
Anticancer Drugs. 2019 Jul;30(6):579-587. doi: 10.1097/CAD.0000000000000743.
2
miR-29a-3p inhibits endometrial cancer cell proliferation, migration and invasion by targeting VEGFA/CD C42/PAK1.miR-29a-3p 通过靶向 VEGFA/CD C42/PAK1 抑制子宫内膜癌细胞增殖、迁移和侵袭。
BMC Cancer. 2021 Jul 21;21(1):843. doi: 10.1186/s12885-021-08506-z.
3
LncRNA-H19 activates CDC42/PAK1 pathway to promote cell proliferation, migration and invasion by targeting miR-15b in hepatocellular carcinoma.长链非编码 RNA-H19 通过靶向 miR-15b 激活 CDC42/PAK1 通路促进肝癌细胞增殖、迁移和侵袭。
Genomics. 2019 Dec;111(6):1862-1872. doi: 10.1016/j.ygeno.2018.12.009. Epub 2018 Dec 10.
4
Downregulation of miR-146a promotes tumorigenesis of cervical cancer stem cells via VEGF/CDC42/PAK1 signaling pathway.miR-146a 的下调通过 VEGF/CDC42/PAK1 信号通路促进宫颈癌干细胞的肿瘤发生。
Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):3711-3719. doi: 10.1080/21691401.2019.1664560.
5
miR-29a/b/c function as invasion suppressors for gliomas by targeting CDC42 and predict the prognosis of patients.miR-29a/b/c通过靶向CDC42发挥胶质瘤侵袭抑制因子的作用,并可预测患者的预后。
Br J Cancer. 2017 Sep 26;117(7):1036-1047. doi: 10.1038/bjc.2017.255. Epub 2017 Aug 8.
6
MiR-509-3p Induces Apoptosis and Affects the Chemosensitivity of Cervical Cancer Cells by Targeting the RAC1/PAK1/LIMK1/Cofilin Pathway.miR-509-3p 通过靶向 RAC1/PAK1/LIMK1/肌动蛋白丝解聚因子通路诱导宫颈癌细胞凋亡并影响其化疗敏感性。
Chem Pharm Bull (Tokyo). 2021;69(4):325-332. doi: 10.1248/cpb.c20-00600.
7
MiR-29a inhibits invasion and metastasis of cervical cancer via modulating methylation of tumor suppressor SOCS1.miR-29a 通过调节肿瘤抑制因子 SOCS1 的甲基化抑制宫颈癌的侵袭和转移。
Future Oncol. 2019 May;15(15):1729-1744. doi: 10.2217/fon-2018-0497. Epub 2019 Apr 30.
8
Effects of microRNA-29 family members on proliferation and invasion of gastric cancer cell lines.微小RNA-29家族成员对胃癌细胞系增殖和侵袭的影响。
Chin J Cancer. 2010 Jun;29(6):603-10. doi: 10.5732/cjc.009.10597.
9
miR-130b directly targets ARHGAP1 to drive activation of a metastatic CDC42-PAK1-AP1 positive feedback loop in Ewing sarcoma.微小RNA-130b直接靶向ARHGAP1,以驱动尤因肉瘤中转移性细胞分裂周期蛋白42-丝氨酸/苏氨酸蛋白激酶1-激活蛋白1正反馈回路的激活。
Int J Cancer. 2017 Nov 15;141(10):2062-2075. doi: 10.1002/ijc.30909. Epub 2017 Aug 8.
10
Elevated microRNA-130b-5p or silenced ELK1 inhibits self-renewal ability, proliferation, migration, and invasion abilities, and promotes apoptosis of cervical cancer stem cells.miR-130b-5p 水平升高或 ELK1 沉默抑制宫颈癌干细胞的自我更新能力、增殖、迁移和侵袭能力,并促进其凋亡。
IUBMB Life. 2021 Jan;73(1):118-129. doi: 10.1002/iub.2409. Epub 2020 Dec 8.

引用本文的文献

1
MiRNA in cervical cancer: Diagnosis to therapy: Systematic review.宫颈癌中的微小RNA:从诊断到治疗:系统评价
Heliyon. 2024 Jan 12;10(3):e24398. doi: 10.1016/j.heliyon.2024.e24398. eCollection 2024 Feb 15.
2
Serum cell division cycle 42 reflects the treatment response and survival in patients with advanced cervical cancer who receive immune checkpoint inhibitor treatment.血清细胞分裂周期蛋白42反映了接受免疫检查点抑制剂治疗的晚期宫颈癌患者的治疗反应和生存期。
Oncol Lett. 2023 Aug 8;26(3):414. doi: 10.3892/ol.2023.14000. eCollection 2023 Sep.
3
Regulation of ERα-dependent breast cancer metastasis by a miR-29a signaling.
miR-29a 信号通路调控 ERα 依赖型乳腺癌转移
J Exp Clin Cancer Res. 2023 Apr 20;42(1):93. doi: 10.1186/s13046-023-02665-6.
4
LncRNA HCP5 enhances the proliferation and migration of cervical cancer via miR-216a-5p/CDC42 axis.长链非编码RNA HCP5通过miR-216a-5p/CDC42轴增强宫颈癌的增殖和迁移。
J Cancer. 2022 Mar 21;13(6):1882-1894. doi: 10.7150/jca.64730. eCollection 2022.
5
miR‑4306 inhibits the malignant behaviors of colorectal cancer by regulating lncRNA FoxD2‑AS1.miR-4306 通过调控 lncRNA FoxD2-AS1 抑制结直肠癌细胞的恶性行为。
Mol Med Rep. 2021 Oct;24(4). doi: 10.3892/mmr.2021.12362. Epub 2021 Aug 13.
6
miR-29a-3p inhibits endometrial cancer cell proliferation, migration and invasion by targeting VEGFA/CD C42/PAK1.miR-29a-3p 通过靶向 VEGFA/CD C42/PAK1 抑制子宫内膜癌细胞增殖、迁移和侵袭。
BMC Cancer. 2021 Jul 21;21(1):843. doi: 10.1186/s12885-021-08506-z.
7
MicroRNA-29a inhibits cell proliferation and arrests cell cycle by modulating p16 methylation in cervical cancer.微小RNA-29a通过调节宫颈癌中p16的甲基化来抑制细胞增殖并使细胞周期停滞。
Oncol Lett. 2021 Apr;21(4):272. doi: 10.3892/ol.2021.12533. Epub 2021 Feb 9.
8
LncRNA LINC00342 contributes to the growth and metastasis of colorectal cancer via targeting miR-19a-3p/NPEPL1 axis.长链非编码RNA LINC00342通过靶向miR-19a-3p/NPEPL1轴促进结直肠癌的生长和转移。
Cancer Cell Int. 2021 Feb 15;21(1):105. doi: 10.1186/s12935-020-01705-x.
9
Role of microRNAs in epidermal growth factor receptor signaling pathway in cervical cancer.miRNAs 在宫颈癌表皮生长因子受体信号通路中的作用。
Mol Biol Rep. 2020 Jun;47(6):4553-4568. doi: 10.1007/s11033-020-05494-4. Epub 2020 May 7.